• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Lean vs. obese phenotypes of nonalcoholic fatty liver disease: similar or different?

作者信息

Chun Ho Soo, Lee Minjong

机构信息

Department of Internal Medicine, Ewha Womans University College of Medicine, Seoul, Korea.

Department of Internal Medicine, Ewha Womans University Medical Center, Seoul, Korea.

出版信息

Clin Mol Hepatol. 2023 Apr;29(2):377-380. doi: 10.3350/cmh.2023.0061. Epub 2023 Mar 9.

DOI:10.3350/cmh.2023.0061
PMID:36907573
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10121299/
Abstract
摘要

相似文献

1
Lean vs. obese phenotypes of nonalcoholic fatty liver disease: similar or different?非酒精性脂肪性肝病的消瘦型与肥胖型表型：相似还是不同？
Clin Mol Hepatol. 2023 Apr;29(2):377-380. doi: 10.3350/cmh.2023.0061. Epub 2023 Mar 9.
2
Lean or Non-obese Nonalcoholic Fatty Liver Disease Patients: Are They Really Lean?消瘦或非肥胖型非酒精性脂肪性肝病患者：他们真的消瘦吗？
Clin Mol Hepatol. 2023 Oct;29(4):980-983. doi: 10.3350/cmh.2023.0250. Epub 2023 Aug 16.
3
The Future of Nonalcoholic Fatty Liver Disease Treatment.非酒精性脂肪性肝病治疗的未来。
Med Clin North Am. 2019 Jan;103(1):57-69. doi: 10.1016/j.mcna.2018.08.005. Epub 2018 Nov 1.
4
Nonalcoholic fatty liver disease in lean subjects: Prognosis, outcomes and management.非酒精性脂肪性肝病在瘦人群体中的：预后、结局和管理。
World J Gastroenterol. 2020 Nov 14;26(42):6514-6528. doi: 10.3748/wjg.v26.i42.6514.
5
Liver and Cardiovascular Damage in Patients With Lean Nonalcoholic Fatty Liver Disease, and Association With Visceral Obesity.瘦型非酒精性脂肪性肝病患者的肝脏和心血管损伤，及其与内脏肥胖的关系。
Clin Gastroenterol Hepatol. 2017 Oct;15(10):1604-1611.e1. doi: 10.1016/j.cgh.2017.04.045. Epub 2017 May 26.
6
Nonalcoholic fatty liver disease: a systematic review.非酒精性脂肪性肝病：系统评价。
JAMA. 2015 Jun 9;313(22):2263-73. doi: 10.1001/jama.2015.5370.
7
Comparison between obese and non-obese nonalcoholic fatty liver disease.肥胖与非肥胖非酒精性脂肪性肝病的比较。
Clin Mol Hepatol. 2023 Feb;29(Suppl):S58-S67. doi: 10.3350/cmh.2022.0350. Epub 2022 Dec 5.
8
Simultaneous Metabolic and Alcohol-associated Fatty Liver Disease (SMAFLD) and Simultaneous Metabolic and Alcohol-associated Steatohepatitis (SMASH).同时性代谢性和酒精相关性脂肪性肝病（SMAFLD）以及同时性代谢性和酒精相关性脂肪性肝炎（SMASH）。
Ann Hepatol. 2021 Sep-Oct;24:100526. doi: 10.1016/j.aohep.2021.100526.
9
The impact of body mass index on clinicopathological features of nonalcoholic fatty liver disease in Taiwan.台湾地区体重指数对非酒精性脂肪性肝病临床病理特征的影响。
J Gastroenterol Hepatol. 2022 Oct;37(10):1901-1910. doi: 10.1111/jgh.15936. Epub 2022 Jul 13.
10
Frequency of Cardiovascular Events and Effect on Survival in Liver Transplant Recipients for Cirrhosis Due to Alcoholic or Nonalcoholic Steatohepatitis.酒精性或非酒精性脂肪性肝炎所致肝硬化肝移植受者心血管事件的发生率及其对生存的影响
Exp Clin Transplant. 2016 Feb;14(1):79-85. doi: 10.6002/ect.2015.0089. Epub 2015 Nov 17.

引用本文的文献

1
Genetic and epigenetic determinants of non-alcoholic fatty liver disease (NAFLD) in lean individuals: a systematic review.瘦人非酒精性脂肪性肝病（NAFLD）的遗传和表观遗传决定因素：一项系统综述。
Transl Gastroenterol Hepatol. 2023 Dec 6;9:11. doi: 10.21037/tgh-23-31. eCollection 2024.
2
Lean or Non-obese Nonalcoholic Fatty Liver Disease Patients: Are They Really Lean?消瘦或非肥胖型非酒精性脂肪性肝病患者：他们真的消瘦吗？
Clin Mol Hepatol. 2023 Oct;29(4):980-983. doi: 10.3350/cmh.2023.0250. Epub 2023 Aug 16.

本文引用的文献

1
Non-alcoholic fatty liver disease: Definition and subtypes.非酒精性脂肪性肝病：定义和亚型。
Clin Mol Hepatol. 2023 Feb;29(suppl):S5-S16. doi: 10.3350/cmh.2022.0424. Epub 2022 Dec 28.
2
Pharmacological advances in the treatment of nonalcoholic fatty liver diseases : focused on global results of randomized controlled trials.治疗非酒精性脂肪性肝病的药理学进展：重点关注随机对照试验的全球结果。
Clin Mol Hepatol. 2023 Feb;29(Suppl):S268-S275. doi: 10.3350/cmh.2022.0437. Epub 2022 Dec 20.
3
Comparison between obese and non-obese nonalcoholic fatty liver disease.肥胖与非肥胖非酒精性脂肪性肝病的比较。
Clin Mol Hepatol. 2023 Feb;29(Suppl):S58-S67. doi: 10.3350/cmh.2022.0350. Epub 2022 Dec 5.
4
Interaction between sarcopenia and nonalcoholic fatty liver disease.肌少症与非酒精性脂肪性肝病的相互作用。
Clin Mol Hepatol. 2023 Feb;29(Suppl):S68-S78. doi: 10.3350/cmh.2022.0358. Epub 2022 Dec 5.
5
Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach.采用分层贝叶斯方法预测 2040 年非酒精性脂肪性肝病的全球患病率。
Clin Mol Hepatol. 2022 Oct;28(4):841-850. doi: 10.3350/cmh.2022.0239. Epub 2022 Sep 19.
6
Comparative Burden of Metabolic Dysfunction in Lean NAFLD vs Non-lean NAFLD - A Systematic Review and Meta-analysis.非肥胖性非酒精性脂肪性肝病（NAFLD）患者与非非肥胖性 NAFLD 患者代谢功能障碍负担的比较：系统评价和荟萃分析。
Clin Gastroenterol Hepatol. 2023 Jul;21(7):1750-1760.e12. doi: 10.1016/j.cgh.2022.06.029. Epub 2022 Jul 19.
7
Ethyl glucuronide in hair detects a high rate of harmful alcohol consumption in presumed non-alcoholic fatty liver disease.头发中的乙基葡糖苷检测到疑似非酒精性脂肪性肝病患者中有很高的有害饮酒率。
J Hepatol. 2022 Oct;77(4):918-930. doi: 10.1016/j.jhep.2022.04.040. Epub 2022 May 20.
8
Nonalcoholic fatty liver disease and accelerated loss of skeletal muscle mass: A longitudinal cohort study.非酒精性脂肪性肝病与骨骼肌质量加速丢失：一项纵向队列研究。
Hepatology. 2022 Dec;76(6):1746-1754. doi: 10.1002/hep.32578. Epub 2022 Jun 10.
9
Old and new classes of glucose-lowering agents as treatments for non-alcoholic fatty liver disease: A narrative review.新旧降糖药物治疗非酒精性脂肪性肝病：叙述性综述。
Clin Mol Hepatol. 2022 Oct;28(4):725-738. doi: 10.3350/cmh.2022.0015. Epub 2022 Mar 14.
10
Association of Physical Activity With Risk of Liver Fibrosis, Sarcopenia, and Cardiovascular Disease in Nonalcoholic Fatty Liver Disease.体力活动与非酒精性脂肪性肝病患者肝纤维化、肌肉减少症和心血管疾病风险的相关性。
Clin Gastroenterol Hepatol. 2023 Feb;21(2):358-369.e12. doi: 10.1016/j.cgh.2021.12.043. Epub 2022 Jan 6.